Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 24Terminated 14Recruiting 11Unknown 3Active not recruiting 2No longer available 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 18Myeloid 3Thoracic 1Sarcoma 1Plasma cell 1Other solid neoplasm 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Myelodysplastic Syndromes 92Leukemia, Myelogenous, Chronic, BCR-ABL Positive 82Leukemia, Myeloid, Acute 79Leukemia 41Myeloproliferative Disorders 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 30Multiple Myeloma 21Leukemia, Myeloid, Chronic-Phase 20Lymphoma, Non-Hodgkin 18Lymphoma 18Leukemia, Lymphocytic, Chronic, B-Cell 17Leukemia, Myelomonocytic, Chronic 16Polycythemia Vera 14Hodgkin Disease 14Primary Myelofibrosis 11Lymphoma, Large B-Cell, Diffuse 11Neoplasms, Plasma Cell 10Lymphoma, Follicular 10Hematologic Neoplasms 10Burkitt Lymphoma 10Recurrence 9Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9Anemia, Refractory, with Excess of Blasts 9Myelodysplastic-Myeloproliferative Diseases 8Mastocytosis, Systemic 8Mastocytosis 8Lymphoma, Mantle-Cell 8Lymphoma, Large-Cell, Immunoblastic 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myeloid, Accelerated Phase 8

Interventions

flumatinib 1Imatinib Mesylate 1Deferasirox 1Blood Specimen Collection 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myeloid × Myeloid × Clear all
NCT03659084 2018-09-06

GREFFE

Hospices Civils de Lyon

Unknown
150 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02489929 2015-07-03

Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine

Assistance Publique Hopitaux De Marseille

Phase NA Unknown
35 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Myelodysplastic Syndromes

NCT01503502 2013-04-10

A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Unknown
150 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡